Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Performance Optimization Platform (P-POP) for Long Duration Spaceflight

NCT06979570 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06979570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Performance Optimization Platform (P-POP) for Long Duration Spaceflight
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
February 22, 2021
Completion date
September 30, 2025
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

countermeasure evaluation, neurocognitive function, performance assessment, psychological factors, sensory science